AIIMS Delhi to begin clinical trials for COVID-19 vaccine on 6-12 age group from Tuesday

The clinical trials will try to evaluate the safety, reactogenicity and immunogenicity of Bharat Biotech's Covaxin jabs in children.

https://ift.tt/eA8V8J from https://ift.tt/3glyY4v
by -
Tags

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Punjab govt announces Rs 1 crore cash award to India men`s hockey team players from the state

Indian men's hockey team on Thursday morning created history at the Tokyo Olympics by winning a bronze, their first medal in 41 years fr...